TGA Change Impact Assessment for Australian Medical Device Approval
Assess device changes before they disrupt your Australian market access. Elexes helps manufacturers determine whether design, labeling, software, manufacturing, or intended-use updates trigger a TGA notification, variation, or new ARTG application, with clear regulatory rationale and defensible documentation aligned to Australia’s medical device framework.
Our TGA Change Impact Assessment Services
Targeted regulatory support for assessing, documenting, and managing device changes under TGA requirements.
Change Assessment
Structured evaluation of design, software, labeling, manufacturing, and intended-purpose changes to determine whether they affect ARTG inclusion or require further TGA action.
ARTG Variation Support
Guidance on whether a proposed change needs a TGA notification, application for variation, or a new ARTG application, with supporting rationale and documentation.
TGA Documentation Alignment
Review and alignment of technical documentation, risk management, and conformity assessment evidence so change decisions remain consistent with Australian regulatory expectations.
Labeling Review
Assessment of Australian labeling and IFU updates against TGA requirements, including market-specific content, presentation standards, and compliance implications of revisions.
Risk Alignment
Cross-checking proposed changes against ISO 14971-based risk management outputs to confirm safety, performance, and Essential Principles evidence remain properly supported.
Submission Readiness
Readiness support when a change triggers regulatory action, helping your team prepare complete, defensible materials before engaging the TGA or sponsor.
Defensible Change Decisions
Protect Australian Market Access With Clarity
When an ARTG-listed device changes, the regulatory question is not whether the update seems minor internally, but whether it affects the basis of Australian approval. Elexes delivers structured TGA change impact assessments that evaluate the change, map it to applicable requirements, and provide a clear determination your team can defend during sponsor review, TGA scrutiny, or future audits.
Trusted By Manufacturers
Success Stories
Supporting medical device teams with defensible regulatory decisions across complex global approval pathways.
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Having Elexes as our import-export expert was a great choice. Elexes’ team answered all our questions and guided us through every step.”
Linda Pan
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Having Elexes as our import-export expert was a great choice. Elexes’ team answered all our questions and guided us through every step.”
Linda Pan
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Having Elexes as our import-export expert was a great choice. Elexes’ team answered all our questions and guided us through every step.”
Linda Pan
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
The Elexes Difference
Why Choose Elexes?
Manufacturers rely on Elexes for rigorous regulatory judgment and practical execution.
Deep Experience
50+ years of collective experience across medical device regulatory and compliance work.
TGA Expertise
We assess Australian device changes against ARTG obligations, Essential Principles, and market-specific documentation expectations.
End-to-End Support
From impact assessment through remediation, variation support, and submission readiness, your team gets continuity.
Proven Results
250+ successful projects and 90% audit clearance support confident, audit-ready regulatory decision-making.
Meet The Elexes Team
Experienced regulatory specialists supporting complex device approvals.
Elexes is a trusted medical device regulatory consulting partner supporting manufacturers across global markets, including Australia. Our team helps companies navigate complex approval pathways, technical documentation demands, and post-approval obligations with the discipline needed for high-stakes regulatory decisions. For Australian medical device approval work, we bring practical experience in TGA expectations, ARTG inclusion pathways, and the documentation alignment needed when device changes affect safety, performance, labeling, software, or manufacturing. With 50+ years of collective experience, Elexes supports organizations from early planning through approval and post-market change governance, helping teams reduce avoidable delays, strengthen regulatory defensibility, and maintain commercial continuity when product updates must be assessed correctly the first time.
250+ ProjectsSuccessful regulatory and compliance engagements completed.200+ Product TypesExperience across diverse medical device categories.90% Audit ClearanceStrong track record in audit and inspection support.
Frequently Asked Questions
What does TGA assess?
The TGA assesses whether a medical device meets applicable Australian regulatory requirements for safety, performance, classification, conformity assessment evidence, labeling, and inclusion in the ARTG. For post-approval changes, the TGA also considers whether updates to design, software, manufacturing, materials, or intended purpose affect the basis on which the device was originally approved and supplied in Australia.
What is TGA assessment?
TGA assessment is the regulatory review process used to determine whether a medical device and its supporting evidence satisfy Australian requirements under the Therapeutic Goods framework. Depending on the situation, this can involve reviewing classification, technical documentation, conformity assessment evidence, sponsor arrangements, labeling, risk management, and whether a proposed device change requires notification, variation, or a new ARTG application.
When is a TGA change impact assessment needed?
A TGA change impact assessment is needed whenever an ARTG-listed device undergoes a meaningful update to design, materials, manufacturing process, software, labeling, sterilization, intended purpose, or supply configuration. The assessment determines whether the change affects safety, performance, or the original conformity assessment basis, and whether regulatory action is required before implementation or continued supply in Australia.
What types of changes can trigger a TGA notification or variation?
Changes that may trigger TGA action include modifications to device design, raw materials, manufacturing sites or processes, software functionality, indications for use, labeling content, packaging, sterilization methods, and conformity assessment evidence. The key issue is whether the change alters the approved device in a way that affects compliance, safety, performance, or the regulatory basis of the ARTG inclusion.
Can labeling changes affect Australian medical device approval?
Yes. Labeling and IFU changes can affect Australian approval if they alter intended purpose, claims, warnings, mandatory content, presentation, or UDI-related obligations. Even when a change appears administrative, it should be reviewed against TGA requirements such as Schedule 1 expectations and applicable labeling guidance to confirm whether the update can proceed as documented or needs formal regulatory action.
How does Elexes document a change impact assessment?
Elexes documents the nature of the proposed change, the affected device elements, the regulatory framework applied, the conformity assessment implications, and the final determination. The output is a structured, defensible record that can support internal change control, sponsor review, audit readiness, and any required TGA notification, variation, or new application activity tied to the assessed change.
Does software change require a new TGA application?
Not every software change requires a new TGA application, but software updates should always be assessed carefully. Changes to algorithms, intended use, clinical functionality, cybersecurity controls, user interface behavior, or performance claims can alter the regulatory position of the device. A formal impact assessment helps determine whether the update is manageable within existing approval or triggers further TGA action.
How long does a change impact assessment usually take?
Timing depends on the complexity of the device, the number of affected documents, and whether the change touches multiple regulatory elements such as labeling, risk management, software, and manufacturing. Straightforward assessments can move quickly once documentation is available, while complex portfolio or multi-market changes take longer. The goal is a complete, evidence-based determination rather than a rushed opinion that creates later regulatory exposure.
Still Have Questions About TGA Changes?
Speak with our regulatory experts about your device update.
Markets We Support
Elexes supports medical device manufacturers across Australia and other regulated markets with specialized regulatory consulting services.
Australia + Global Markets
Service Reach
250+ Successful Projects
Project Record
100+ Global Clients
Client Coverage
Australia
USA
Canada
Europe
UK
Asia
Hong Kong
Saudi Arabia
Need Support For Your Market?
Ask if your device change falls within our scope.
Certified & Trusted
Awards and Recognition
ISO 13485
Medical device quality systems expertise.
MDSAP
Supports multi-market audit readiness.
IEC 62304
Software lifecycle compliance capability.
